DZ Bank
NVCR icon

DZ Bank’s NovoCure NVCR Stock Holding History

DZ Bank’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
98,786
-55,213
-36% -$835K ﹤0.01% 696
2026
Q1 		$1.68M Buy
153,999
+81,050
+111% +$1.01M ﹤0.01% 650
2025
Q4 		$943K Buy
+72,949
New +$936K ﹤0.01% 720

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

DZ Bank's NVCR Position: Q2 2026 in Review

DZ Bank reduced its NovoCure (NVCR) stake by 36% in Q2 2026, selling an estimated $835K and leaving 98,786 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #696.

DZ Bank first reported a position in NVCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.68M in Q1 2026. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • DZ Bank held 98,786 shares of NovoCure worth $1.5M as of Q2 2026.
  • DZ Bank sold 55,213 NovoCure shares in Q2 2026, an estimated $835K.
  • NovoCure made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #696 holding.
  • DZ Bank first reported a position in NovoCure in Q4 2025 and has held it in 3 quarters since.
  • DZ Bank's NovoCure position peaked at $1.68M in Q1 2026.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.